CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Baylis Versacross RF wire +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04645342
NCT04645342N/ACompleted
CompareCT.gov

Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency

University of California, San Francisco·interventional·Posted Nov 27, 2020·Updated Mar 14, 2023

In Brief

A clinical study evaluating Baylis Versacross RF wire and Baylis RF needle for Atrial Fibrillation and Atrial Flutter. Completed, enrolled 75 participants across 1 site.

Detailed Summary

This is a randomized controlled trial examining whether Baylis's Versacross RF wire versus the conventional Baylis RF needle is better at puncturing through a thin wall in the heart (called "transseptal puncture") as measured by time to successful transseptal puncture, during cardiac ablation procedures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Atrial Flutter
CountriesUnited States
CollaboratorsBaylis Medical Company

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 27, 2020
Enrollment StartNov 30, 2020
Primary CompletionFeb 2, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.6 years ago

Interventions

Baylis Versacross RF wiredevice

Baylis Versacross radiofrequency wire is used for transseptal puncture during cardiac ablation procedure.

Baylis RF needledevice

Baylis radiofrequency needle is used for transseptal puncture during cardiac ablation procedure.